BACKGROUND Progressive familial intrahepatic cholestasis(PFIC)encompasses a group of autosomal recessive disorders with high morbidity and mortality.Variants in the gene encoding tight junction protein-2(TJP2)have bee...BACKGROUND Progressive familial intrahepatic cholestasis(PFIC)encompasses a group of autosomal recessive disorders with high morbidity and mortality.Variants in the gene encoding tight junction protein-2(TJP2)have been linked to PFIC type 4(PFIC4),which predominantly presents in childhood.However,there are only limited data from adults with TJP2-related PFIC4.We report a family with an autosomal recessive disorder with a novel variant in the TJP2 gene in adults with very variable expression of PFIC4.CASE SUMMARY The index patient presented at 19 years old with liver cirrhosis and variceal bleeding and was treated with endoscopic banding and beta-blockers.In 2018,he developed primary liver cancer that was treated with radiofrequency ablation followed by liver transplantation in 2019.Genetic testing revealed a novel homozygous TJP2 variant causing PFIC4(TJP2([NM_004817.3]:c.[3334C>T];[3334C>T])).The consanguineous family consists of the father and mother(both heterozygous)and their 12 children,of which five carry the variant in a homozygous state;however,these five siblings have highly variable expression of PFIC4.Two homozygous brothers had cirrhosis and portal hypertension at diagnosis at the ages of 19 and 36.Two other homozygous brothers,age 23 and 19,and the homozygous sister,age 21,have elevated liver enzymes but presently no cirrhosis,which may suggest an age-dependent penetrance.In addition,five sisters had severe and mild intrahepatic cholestasis of pregnancy and carry the TJP2 variant in a homozygous and heterozygous state,respectively.CONCLUSION This novel TJP2 variant is associated with PFIC4 causing severe liver disease with cirrhosis and primary liver cancer in adolescents/adults.展开更多
Saccharomycopsis ferment filtrate (SFF), mainly used in skin care products, has been reported to inhibit inflammatory nitric oxide production and prevent epidermal damage. However, the effects of SFF on epidermal kera...Saccharomycopsis ferment filtrate (SFF), mainly used in skin care products, has been reported to inhibit inflammatory nitric oxide production and prevent epidermal damage. However, the effects of SFF on epidermal keratinocytes have not yet been explored. We investigated the effects of SFF on skin barrier function using human primary epidermal keratinocytes. Cell viability was determined by MTT assay. The mRNA and protein expression levels of tight junction proteins (claudin-1, -3, -4, occludin, ZO-1) were analyzed by RT-PCR and Western blotting, respectively. The effect of SFF on the barrier formation of epidermal keratinocytes was measured by transepithelial electrical resistance (TER). Rescue of cell death from H2O2 treatment was evaluated by annexin V staining. SFF, at concentrations that did not cause significant change of cell viability, induced dose-dependent cell-cell adhesion and formation of an organized monolayer structure. Pretreatment of keratinocytes with EGTA, a Ca2+ chelator, did not inhibit the cell-cell adhesion of keratinocytes by SFF, indicating a Ca2+-independent mechanism. The mRNA and protein levels of claudin-1 in keratinocytes were up-regulated by SFF treatment in a dose-dependent manner. The expressions of other tight junctions (TJs) including claudin-3 & 4, occludin and ZO-1 were also similarly increased in SFF-treated epidermal keratinocytes. The promoting effect of SFF on the barrier function of epidermal keratinocytes was further confirmed by the increased TER value in SFF-treated epidermal keratinocytes. Annexin V staining confirmed that SFF markedly decreased the number of dead cells resulted from H2O2 injury. Taken together, our results provided the first evidence that SFF enhanced keratinocytes barrier function by increasing the expression of TJs and TER.展开更多
目的:探讨缝隙连接蛋白beta2(GJB2)基因rs2274083、rs2274084和rs72474224位点多态性与汉族人群职业噪声性听力损失易感性之间的关系。方法:应用1∶1病例-对照研究,病例组177例为电测听结果双耳高频平均听阈≥40 d B的在岗工人,对照组17...目的:探讨缝隙连接蛋白beta2(GJB2)基因rs2274083、rs2274084和rs72474224位点多态性与汉族人群职业噪声性听力损失易感性之间的关系。方法:应用1∶1病例-对照研究,病例组177例为电测听结果双耳高频平均听阈≥40 d B的在岗工人,对照组177例为年龄、性别、作业工龄与病例组相匹配,并且电测听结果双耳高频平均听阈<25 d B的同岗位轮班工人。采用PCR扩增177对样本目的基因片段,对目的基因片段进行测序,确定待研究位点的基因型。结果:GJB2基因的rs2274084位点C、T等位基因频率在病例组和对照组中分布分别为73.73%、26.27%和63.84%、36.16%,其中CC、TC、TT基因型在病例组和对照组中的分布分别为55.37%、36.72%、7.91%和40.11%、47.46%、12.43%。该位点的基因型频率与等位基因频率在病例与对照组之间的差异均具有统计学意义(P<0.05)。rs2274083和rs72474224位点基因型分布在病例与对照组间的差异均无统计学意义(P>0.05)。结论:GJB2rs2274084可能是汉族人群职业噪声性听力损失的易感基因位点,携带C等位基因的工人,暴露职业噪声时更易发生听力损失。展开更多
目的分析内蒙古地区23个非综合征型耳聋家系缝隙连接蛋白β2(gap junction protein beta 2,GJB2)基因突变特点,探讨该耳聋家系遗传学病因。方法对内蒙古地区23个非综合征型遗传性聋家系共122人进行问卷调查、听力学检查,提取外周血DNA,...目的分析内蒙古地区23个非综合征型耳聋家系缝隙连接蛋白β2(gap junction protein beta 2,GJB2)基因突变特点,探讨该耳聋家系遗传学病因。方法对内蒙古地区23个非综合征型遗传性聋家系共122人进行问卷调查、听力学检查,提取外周血DNA,经聚合酶链反应(PCR)扩增GJB2基因编码区进行直接测序,运用DNAStar软件进行测序结果分析。结果共检测到8个家系46名家系个体存在8种GJB2基因核酸序列改变。包括5种致病突变及3种多态性改变,明确了6个耳聋家系的遗传学病因为GJB2基因纯合突变所致。GJB2基因突变在23个家系中的检出率为33%(8/23),在122个家系个体的检出率为33%(37/122),在62例耳聋患者中的检出率为60%(37/62)。c.235delC突变检出率最高,为52%(32/62),其次为c.299-300delAT,突变携带率为8%(5/62)。结论内蒙古地区家系遗传性聋GJB2基因突变有较高的携带率,c.235delC位点是最常见的致病位点,其次为c.299-300delAT。以散发耳聋患者为根源,对其亲属进行耳聋基因筛查可以更加高效的发现潜在的耳聋基因突变携带者。展开更多
目的:研究非霍奇金淋巴瘤(non-hodgkin's lymphoma,NHL)中微小染色体维持蛋白2(Minichromosome maintenance protein 2,MCM2)与细胞间隙连接蛋白43(Connexin 43,Cx43)以及S期激酶相关蛋白2(S phase kinase-associated protein 2,Sk...目的:研究非霍奇金淋巴瘤(non-hodgkin's lymphoma,NHL)中微小染色体维持蛋白2(Minichromosome maintenance protein 2,MCM2)与细胞间隙连接蛋白43(Connexin 43,Cx43)以及S期激酶相关蛋白2(S phase kinase-associated protein 2,Skp2)在非霍奇金淋巴瘤中的表达及临床意义,以期为临床诊治非霍奇金淋巴瘤提供一定的参考。方法:选取2013年1月至2015年1月间入院诊治的非霍奇金淋巴瘤36例作为实验组,并选取同期入院诊治的淋巴结反应性增生18例作为对照组,应用免疫组化法检测MCM2、Cx43、Skp2的表达情况,同时分析MCM2、Cx43、Skp2的表达与非霍奇金淋巴瘤恶性程度、临床分期等的相关性。结果:实验组NHL患者MCM2阳性表达率为83.33%、Skp2阳性表达率为86.11%,显著高于对照组22.22%与27.78%的阳性表达率(P<0.01);NHL患者Cx43阳性表达率为22.22%,显著低于对照组61.11%阳性表达率(P<0.01)。NHL患者MCM2阳性表达与肿瘤恶性程度、临床分期及Ki67水平密切相关(P<0.05);NHL患者Cx43阳性表达与肿瘤恶性程度呈负相关(P<0.01);NHL患者Skp2阳性表达与肿瘤恶性程度及临床分期密切相关(P<0.05)。结论:MCM2、Cx43、Skp2的异常表达与非霍奇金淋巴瘤的恶性程度密切相关,联合检测MCM2、Cx43、Skp2可为非霍奇金淋巴瘤的诊治提供一定的参考。展开更多
基金Supported by Sanming Project of Medicine in Shenzhen of China,No.SZSM201612074
文摘BACKGROUND Progressive familial intrahepatic cholestasis(PFIC)encompasses a group of autosomal recessive disorders with high morbidity and mortality.Variants in the gene encoding tight junction protein-2(TJP2)have been linked to PFIC type 4(PFIC4),which predominantly presents in childhood.However,there are only limited data from adults with TJP2-related PFIC4.We report a family with an autosomal recessive disorder with a novel variant in the TJP2 gene in adults with very variable expression of PFIC4.CASE SUMMARY The index patient presented at 19 years old with liver cirrhosis and variceal bleeding and was treated with endoscopic banding and beta-blockers.In 2018,he developed primary liver cancer that was treated with radiofrequency ablation followed by liver transplantation in 2019.Genetic testing revealed a novel homozygous TJP2 variant causing PFIC4(TJP2([NM_004817.3]:c.[3334C>T];[3334C>T])).The consanguineous family consists of the father and mother(both heterozygous)and their 12 children,of which five carry the variant in a homozygous state;however,these five siblings have highly variable expression of PFIC4.Two homozygous brothers had cirrhosis and portal hypertension at diagnosis at the ages of 19 and 36.Two other homozygous brothers,age 23 and 19,and the homozygous sister,age 21,have elevated liver enzymes but presently no cirrhosis,which may suggest an age-dependent penetrance.In addition,five sisters had severe and mild intrahepatic cholestasis of pregnancy and carry the TJP2 variant in a homozygous and heterozygous state,respectively.CONCLUSION This novel TJP2 variant is associated with PFIC4 causing severe liver disease with cirrhosis and primary liver cancer in adolescents/adults.
文摘Saccharomycopsis ferment filtrate (SFF), mainly used in skin care products, has been reported to inhibit inflammatory nitric oxide production and prevent epidermal damage. However, the effects of SFF on epidermal keratinocytes have not yet been explored. We investigated the effects of SFF on skin barrier function using human primary epidermal keratinocytes. Cell viability was determined by MTT assay. The mRNA and protein expression levels of tight junction proteins (claudin-1, -3, -4, occludin, ZO-1) were analyzed by RT-PCR and Western blotting, respectively. The effect of SFF on the barrier formation of epidermal keratinocytes was measured by transepithelial electrical resistance (TER). Rescue of cell death from H2O2 treatment was evaluated by annexin V staining. SFF, at concentrations that did not cause significant change of cell viability, induced dose-dependent cell-cell adhesion and formation of an organized monolayer structure. Pretreatment of keratinocytes with EGTA, a Ca2+ chelator, did not inhibit the cell-cell adhesion of keratinocytes by SFF, indicating a Ca2+-independent mechanism. The mRNA and protein levels of claudin-1 in keratinocytes were up-regulated by SFF treatment in a dose-dependent manner. The expressions of other tight junctions (TJs) including claudin-3 & 4, occludin and ZO-1 were also similarly increased in SFF-treated epidermal keratinocytes. The promoting effect of SFF on the barrier function of epidermal keratinocytes was further confirmed by the increased TER value in SFF-treated epidermal keratinocytes. Annexin V staining confirmed that SFF markedly decreased the number of dead cells resulted from H2O2 injury. Taken together, our results provided the first evidence that SFF enhanced keratinocytes barrier function by increasing the expression of TJs and TER.
文摘目的:探讨缝隙连接蛋白beta2(GJB2)基因rs2274083、rs2274084和rs72474224位点多态性与汉族人群职业噪声性听力损失易感性之间的关系。方法:应用1∶1病例-对照研究,病例组177例为电测听结果双耳高频平均听阈≥40 d B的在岗工人,对照组177例为年龄、性别、作业工龄与病例组相匹配,并且电测听结果双耳高频平均听阈<25 d B的同岗位轮班工人。采用PCR扩增177对样本目的基因片段,对目的基因片段进行测序,确定待研究位点的基因型。结果:GJB2基因的rs2274084位点C、T等位基因频率在病例组和对照组中分布分别为73.73%、26.27%和63.84%、36.16%,其中CC、TC、TT基因型在病例组和对照组中的分布分别为55.37%、36.72%、7.91%和40.11%、47.46%、12.43%。该位点的基因型频率与等位基因频率在病例与对照组之间的差异均具有统计学意义(P<0.05)。rs2274083和rs72474224位点基因型分布在病例与对照组间的差异均无统计学意义(P>0.05)。结论:GJB2rs2274084可能是汉族人群职业噪声性听力损失的易感基因位点,携带C等位基因的工人,暴露职业噪声时更易发生听力损失。
文摘目的分析内蒙古地区23个非综合征型耳聋家系缝隙连接蛋白β2(gap junction protein beta 2,GJB2)基因突变特点,探讨该耳聋家系遗传学病因。方法对内蒙古地区23个非综合征型遗传性聋家系共122人进行问卷调查、听力学检查,提取外周血DNA,经聚合酶链反应(PCR)扩增GJB2基因编码区进行直接测序,运用DNAStar软件进行测序结果分析。结果共检测到8个家系46名家系个体存在8种GJB2基因核酸序列改变。包括5种致病突变及3种多态性改变,明确了6个耳聋家系的遗传学病因为GJB2基因纯合突变所致。GJB2基因突变在23个家系中的检出率为33%(8/23),在122个家系个体的检出率为33%(37/122),在62例耳聋患者中的检出率为60%(37/62)。c.235delC突变检出率最高,为52%(32/62),其次为c.299-300delAT,突变携带率为8%(5/62)。结论内蒙古地区家系遗传性聋GJB2基因突变有较高的携带率,c.235delC位点是最常见的致病位点,其次为c.299-300delAT。以散发耳聋患者为根源,对其亲属进行耳聋基因筛查可以更加高效的发现潜在的耳聋基因突变携带者。
文摘目的:研究非霍奇金淋巴瘤(non-hodgkin's lymphoma,NHL)中微小染色体维持蛋白2(Minichromosome maintenance protein 2,MCM2)与细胞间隙连接蛋白43(Connexin 43,Cx43)以及S期激酶相关蛋白2(S phase kinase-associated protein 2,Skp2)在非霍奇金淋巴瘤中的表达及临床意义,以期为临床诊治非霍奇金淋巴瘤提供一定的参考。方法:选取2013年1月至2015年1月间入院诊治的非霍奇金淋巴瘤36例作为实验组,并选取同期入院诊治的淋巴结反应性增生18例作为对照组,应用免疫组化法检测MCM2、Cx43、Skp2的表达情况,同时分析MCM2、Cx43、Skp2的表达与非霍奇金淋巴瘤恶性程度、临床分期等的相关性。结果:实验组NHL患者MCM2阳性表达率为83.33%、Skp2阳性表达率为86.11%,显著高于对照组22.22%与27.78%的阳性表达率(P<0.01);NHL患者Cx43阳性表达率为22.22%,显著低于对照组61.11%阳性表达率(P<0.01)。NHL患者MCM2阳性表达与肿瘤恶性程度、临床分期及Ki67水平密切相关(P<0.05);NHL患者Cx43阳性表达与肿瘤恶性程度呈负相关(P<0.01);NHL患者Skp2阳性表达与肿瘤恶性程度及临床分期密切相关(P<0.05)。结论:MCM2、Cx43、Skp2的异常表达与非霍奇金淋巴瘤的恶性程度密切相关,联合检测MCM2、Cx43、Skp2可为非霍奇金淋巴瘤的诊治提供一定的参考。
